anti vegfa (Proteintech)
Proteintech is a verified supplier 
96
Structured Review
Proteintech
anti vegfa
Anti Vegfa, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 76 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+vegfa/VEGFA+Fusion+Protein/pmc13049530-149-3-5
Average 96 stars, based on 76 article reviews
Anti Vegfa, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 76 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+vegfa/VEGFA+Fusion+Protein/pmc13049530-149-3-5
Average 96 stars, based on 76 article reviews
anti vegfa - by Bioz Stars,
2026-10
96/100 stars
Images
Related Articles
Cell Culture:Article Title: CD73 + mesenchymal stem cell (MSC) transplantation improves pressure ulcer healing by promoting angiogenesis through the HIF-1α/VEGF pathway in diabetic mice. Article Snippet: Diabetic wound healing remains a major clinical challenge.. Although therapies based on mesenchymal stem cells (MSCs) have emerged as promising strategies to address this impairment, the specific contribution of CD73 expression to the therapeutic potential of MSCs has not been previously explored.. In this study, we explored the role of CD73 expression in the therapeutic potential of human adipose tissue-derived mesenchymal stem cells (hADMSCs) for treating diabetic pressure ulcers in a mouse model. Our findings demonstrated that CD73-positive hADMSCs (CD73hADMSCs) could promote enhanced wound healing in diabetic mice and mitigate the endothelial dysfunction caused by high glucose levels. Incubation:Article Title: CD73 + mesenchymal stem cell (MSC) transplantation improves pressure ulcer healing by promoting angiogenesis through the HIF-1α/VEGF pathway in diabetic mice. Article Snippet: Diabetic wound healing remains a major clinical challenge.. Although therapies based on mesenchymal stem cells (MSCs) have emerged as promising strategies to address this impairment, the specific contribution of CD73 expression to the therapeutic potential of MSCs has not been previously explored.. In this study, we explored the role of CD73 expression in the therapeutic potential of human adipose tissue-derived mesenchymal stem cells (hADMSCs) for treating diabetic pressure ulcers in a mouse model. Our findings demonstrated that CD73-positive hADMSCs (CD73hADMSCs) could promote enhanced wound healing in diabetic mice and mitigate the endothelial dysfunction caused by high glucose levels. Article Title: Mitochondria-derived peptide MOTS-c alleviates hyperoxia-induced bronchopulmonary dysplasia in neonatal mice by activating Nrf2 pathway. Article Snippet: Oxidative stress play key roles in the pathogenesis of bronchopulmonary dysplasia (BPD).. MOTS-c is a mitochondria-derived peptide containing 16 amino acids that is reported to be involved in the treatment of oxidative stress-related diseases.. However, whether MOTS-c functions on hyperoxia-induced BPD remains unknown. Article Title: Sohlh2 inhibited the angiogenesis of hepatocellular carcinoma through the HIF-1α/VEGFA pathway Article Snippet: Equal amounts of protein samples were separated by 10 % SDS-PAGE, transferred onto polyvinylidene difluoride membranes (HVLP14250, Millipore, USA), and subsequently obstructed using 5 % nonfat dried milk. .. The membranes were subjected to overnight incubation at 4 °C with the respective primary antibodies: Sohlh2 antibody (1: 500, ab101402, Abcam, UK, RRID: AB_10672266), HIF-1α (1:1000, ab308433, Abcam, UK, RRID: AB_2941086), Blocking Assay:Article Title: CD73 + mesenchymal stem cell (MSC) transplantation improves pressure ulcer healing by promoting angiogenesis through the HIF-1α/VEGF pathway in diabetic mice. Article Snippet: Diabetic wound healing remains a major clinical challenge.. Although therapies based on mesenchymal stem cells (MSCs) have emerged as promising strategies to address this impairment, the specific contribution of CD73 expression to the therapeutic potential of MSCs has not been previously explored.. In this study, we explored the role of CD73 expression in the therapeutic potential of human adipose tissue-derived mesenchymal stem cells (hADMSCs) for treating diabetic pressure ulcers in a mouse model. Our findings demonstrated that CD73-positive hADMSCs (CD73hADMSCs) could promote enhanced wound healing in diabetic mice and mitigate the endothelial dysfunction caused by high glucose levels. Immunohistochemistry:Article Title: Single-cell atlas of pig-to-monkey kidney xenotransplantation reveals macrophage chimerism and an IFN-ε orchestrated graft protective immune niche Article Snippet: .. The primary antibody panel including: anti-IgM (11016-1-AP, 1:100, Proteintech), anti-IgG (ab109489, 1:500, Abcam), C4d (22233-1-AP, 1:200, Proteintech), anti-CD31 (ab28364, 1:50, Abcam), anti-vWF (ab6994, 1:200, Abcam), anti-CD3 (GB12014, 1:1000, Servicebio) and anti-CD15 (YT0726, 1:200, Immunoway) for IHC; anti-CD68 (bs-0649R, 1:200, Bioss), anti-SPP1 (83341-1-RR, 1:200, Proteintech), other:Article Title: Serum metabolic fingerprinting for diagnosis and therapeutic applications of ovarian endometriosis Article Snippet: Anti-VEGFA , |